Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Prostatic Neoplasms 2 Chordoma 2 Triple Negative Breast Neoplasms 1 Sinonasal undifferentiated carcinoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 HER2-positive Breast Cancer 1 Fistula 1 Esthesioneuroblastoma, Olfactory 1 Carcinoma, Squamous Cell 1 Carcinoma, Mucoepidermoid 1 Carcinoma, Adenoid Cystic 1

Interventions

Exercise 18 Drug Therapy 17 pembrolizumab 12 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Protons × Clear all

NCT01182779 2010-08-17

HIT-1

Heidelberg University

Phase 3 Unknown

Chordoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡